Using GM-CSF/IL-4 bone marrow-derived DCs (BMDCs) for vaccination in combination with pomalidomide and PD-L1 blockade, a significant tumor growth inhibition within a multiple myeloma mouse model could be achieved (113). Here, CSF2 is linked to plasma cell myeloma.